Tropisetron reduces postoperative vomiting in children undergoing tonsillectomy

Anette B. Jensen, Dorte B. Christiansen, Kingsley Coulthard, Andrew Wilkins, Greg Roberts, Johan H. Van Der Walt, Mette Rasmussen

Research output: Contribution to journalArticlepeer-review

43 Citations (Scopus)

Abstract

In this patient, parent and investigator blinded, randomized, placebo- controlled study, children undergoing tonsillectomy (mean age 6.4 years) received either intravenous placebo (n = 36) or tropisetron 0.2 mg·kg-1 up to 5 mg (n = 35) at induction of anaesthesia with halothane, nitrous oxide and oxygen. Morphine and paracetamol were given in theatre for postoperative pain. Episodes of vomiting were recorded during the first 24 h after surgery. Intravenous tropisetron was significantly (P < 0.001, chi-squared) more effective than placebo in controlling the incidence and frequency of emesis during the first 24 h: vomiting was reduced from 89% to 46% and the mean number of vomits from 4.6 to 2.4. Minor side-effects occurred equally in both the placebo and active groups. Intravenous tropisetron is an effective and safe antiemetic for reducing postoperative vomiting in children undergoing tonsillectomy or adenotonsillectomy.

Original languageEnglish
Pages (from-to)69-75
Number of pages7
JournalPaediatric Anaesthesia
Volume10
Issue number1
DOIs
Publication statusPublished - Jan 2000
Externally publishedYes

Keywords

  • Antiemetic
  • Complications
  • Pharmacoeconomics
  • Tonsillectomy
  • Tropisetron
  • Vomiting

Fingerprint Dive into the research topics of 'Tropisetron reduces postoperative vomiting in children undergoing tonsillectomy'. Together they form a unique fingerprint.

Cite this